← Browse by Condition
Medical Condition

clear cell rcc

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05581004 Phase 1
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

Enrollment
450 pts
Location
United States, Austr...
Sponsor
Genentech, Inc.
View Trial →